Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 7.7B | 6.8B | 5.8B | 5.5B |
Cost of revenue | 3.8B | 3.4B | 3.0B | 2.9B |
Gross profit | 3.9B | 3.4B | 2.9B | 2.6B |
Operating expense | ||||
Research & development | 1.7B | 1.6B | 1.6B | 1.5B |
Selling general and admin | 792M | 721M | 650M | 620M |
Other operating expenses | -11M | -14M | -10M | -13M |
Operating income | 1.1B | 724M | 269M | 36M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 19M | 23M | 25M | 25M |
Other income expense | -331M | 36M | 55M | 53M |
Pretax income | 889M | 737M | 299M | 64M |
Tax provision | 419M | -27M | 41M | -52M |
Net income | 482M | 771M | 265M | 123M |
Basic EPS | — | 0.5 | 0.2 | 0.1 |
Diluted EPS | — | 0.5 | 0.2 | 0.1 |
Basic average shares | — | 1.8B | 1.8B | 1.8B |
Diluted average shares | — | 1.8B | 1.8B | 1.9B |
EBITDA | 1.7B | 1.5B | 1.1B | 899M |
Net income from continuing op. | 482M | 771M | 265M | 123M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |